Daiichi Sankyo

This early-phase trial tested an experimental drug called DS-7011a in 26 adults with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The study aimed to check the drug's safety and how the body processes it, not yet to prove it works. Participants received either…

This phase 2 trial tested the drug DS-1062a in 137 adults with advanced or metastatic non-small cell lung cancer that has specific genetic changes and has worsened after targeted therapy and chemotherapy. The main goal was to see how many patients' tumors shrank or disappeared. T…

This study tested a new drug, trastuzumab deruxtecan (DS-8201a), against standard treatments for people with advanced HER2-positive breast cancer that had already been treated with T-DM1. The trial included 608 participants whose cancer could not be removed by surgery or had spre…

This study tested a drug called trastuzumab deruxtecan (T-DXd) in 122 people with advanced colorectal cancer that has too much HER2 protein. The goal was to see if the drug could shrink tumors. About 45% of patients had their tumors shrink. This treatment is not a cure, but it ma…

This study tested bempedoic acid, a new cholesterol-lowering drug, in 180 Taiwanese adults with high cholesterol or mixed lipid problems. Participants took a 180 mg tablet daily for 12 weeks. The goal was to see how much it lowered 'bad' LDL cholesterol and whether it was safe, e…

This study tested a drug called trastuzumab deruxtecan in 152 people with advanced non-small cell lung cancer that has a specific genetic change (HER2 mutation) and has stopped responding to standard chemotherapy. The drug is given by IV every three weeks and aims to shrink tumor…

This study checked whether a single pill containing three cholesterol-lowering medicines (bempedoic acid, ezetimibe, and atorvastatin) works the same in the body as taking the three drugs separately. It involved 58 healthy adults aged 18 to 60. The goal was to see if the combinat…

This study tested whether a single pill containing three cholesterol-lowering drugs (bempedoic acid, ezetimibe, and atorvastatin) works the same as taking them separately. 58 healthy adults participated in a crossover trial where they received both forms. The goal was to see if t…

This study checked if a single pill containing three cholesterol-lowering drugs works the same as taking them separately. It involved 58 healthy adults aged 18 to 60. The goal was to see if the combination pill is absorbed similarly, not to treat any disease.

This study tested whether a single pill containing three cholesterol-lowering drugs (bempedoic acid, ezetimibe, and rosuvastatin) works the same as taking them separately. Fifty-eight healthy adults each received both the combination pill and the individual pills at different tim…

This study looked at medical records from 509 adults in Taiwan to find out how often advanced cervical, endometrial, and ovarian cancers have a specific marker called HER2 IHC 3+. Researchers also described the patients' health details to better understand who might benefit from …

This completed study analyzed data from 1,415 patients with HR-positive, HER2-negative metastatic breast cancer in the United States. Researchers looked at what happened after patients progressed on their first-line treatment (endocrine therapy plus a CDK4/6 inhibitor) and starte…

This study looked at how safe and effective the blood thinner edoxaban is for preventing strokes in people aged 80 or older with a common heart rhythm problem called atrial fibrillation. Researchers followed over 1,200 patients in Korea who were already prescribed edoxaban by the…